Progyny, Inc. Common Stock (PGNY) is a publicly traded Healthcare sector company. As of September 3, 2026, PGNY trades at $26.70 with a market cap of $1.97B and a P/E ratio of 27.21. PGNY moved +1.48% today. Year to date, PGNY is +2.14%; over the trailing twelve months it is +11.68%. Its 52-week range spans $16.10 to $33.07. Analyst consensus is strong buy with an average price target of $34.30. Rallies surfaces PGNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PGNY combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $26.70 |
| Market Cap | $1.97B |
| P/E Ratio | 27.21 |
| EPS | $0.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.07 |
| 52-Week Low | $16.10 |
| Volume | 329.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.31B |
| Net Income | $78.63M |
| Gross Margin | 24.57% |
10 analysts cover PGNY: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.30.